Colchicine as a novel drug for the treatment of osteosarcoma through drug repositioning based on an FDA drug library
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.893951
Abstract: Background Colchicine is a traditional medication that is currently approved to treat gout and familial Mediterranean fever (FMF). However, colchicine has a wide range of anti-inflammatory activities, and several studies have indicated that it may… read more here.
Keywords: u2os cells; colchicine; saos u2os; treatment ... See more keywords